Mirae Asset Global ETFs Holdings’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$765K Buy
5,742
+729
+15% +$82.5K ﹤0.01% 1770
2026
Q1
$558K Buy
+5,013
New +$593K ﹤0.01% 1837

Other funds holding ABVX

Mirae Asset Global ETFs Holdings's ABVX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Abivax (ABVX) stake by 15% in Q2 2026, buying an estimated $82.5K and bringing the position to 5,742 shares worth $765K. The position accounts for ﹤0.01% of the portfolio, ranked #1770.

Mirae Asset Global ETFs Holdings first reported a position in ABVX in Q1 2026 and has held it in 2 quarters since. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 5,742 shares of Abivax worth $765K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 729 Abivax shares in Q2 2026, an estimated $82.5K.
  • Abivax made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1770 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Abivax in Q1 2026 and has held it in 2 quarters since.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.